Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In China-Biotics, Inc. Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at China-Biotics, Inc. (“China-Biotics” or the “Company”) (OTC: CHBT).
The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (1) China-Biotics had prepared a false sales contract; (2) the Company had published a false bank website; and (3) China-Biotics had issued false bank advice with the aim of showing that the Company had achieved a 50% growth in 2011 revenue.
If you purchased China-Biotic securities between February 9, 2011 and July 1, 2011 and would like to discuss your legal rights, contact us by calling Juan Monteverde, Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org, email@example.com or firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding China-Biotic’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.